FDA
approval
· 2017-08-15
FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
Summary
FDA approved a supplemental application for GENVOYA (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) from Gilead Sciences. The approval upda…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE)